Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Carcinogenicity of the food additive furylfuramide in foetal and young mice

Abstract

FURYLFURAMIDE (so-called AF-2), 2-(2-furyl)-3-(5-nitro-2-furyl) acrylic acid amide, had been used widely (probably several tonnes yr−1) as an antimicrobial food additive in such food as fish sausage, mixed meat sausage, boiled fish paste and soybean curd throughout Japan until it was banned in 1974. Tonomura and Sasaki1 found that furylfuramide induces chromosome aberrations in cultured human lymphocytes and strong mutagenicity was found by Kada2 and Kondo and Ichikawa-Ryo3 with E. coil. Miyaji4 had reported, however, that neither tumour nor malformation was induced by furylfuramide in rats and mice, although Morris et al.5 reported that some other nitrofuran derivatives induced tumours in rats. Ames and his associates6,7 have shown that almost 90% of chemical carcinogens so far tested are mutagenic in their specified tester strains of Salmonella typhimurium. Thus, furylfuramide has been an important exception to the presumptive rule that a carcinogen is, in principle, a mutagen. As fish sausage has been favoured so much by young Japanese children, it was necessary to reopen the question of the carcinogenicity of furylfuramide in view of its strong mutagenicity. I report here that furylfuramide induces low but significant yields of tumours in mice when administered at the foetal or young stage.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Tonomura, A., and Sasaki, M. S., Jap. J. Genet., 48, 291–294 (1973).

    Article  Google Scholar 

  2. Kada, T., Jap. J. Genet., 48, 301–305 (1973).

    Article  Google Scholar 

  3. Kondo, S., and Ichikawa-Ryo, H., Jap. J. Genet., 48, 295–300 (1973).

    Article  Google Scholar 

  4. Miyaji, T., Tohoku. J. exp. Med., 103, 331–369, 381–388 (1971).

    Article  CAS  Google Scholar 

  5. Morris, J. E., Price, J. M., Lalich, J. J., and Stein, R. J., Cancer Res., 29, 2145–2156 (1969).

    CAS  PubMed  Google Scholar 

  6. Ames, B. N., Durston, W. E., Yamasaki, E., and Lee, F. D., Proc. natn. Acad. Sci. U.S.A., 70, 2281–2285 (1973).

    Article  ADS  CAS  Google Scholar 

  7. McCann, J., Spingarn, N. E., Kobori, J., and Ames, B. N., Proc. natn. Acad. Sci. U.S.A., 72, 979–983 (1975).

    Article  ADS  CAS  Google Scholar 

  8. Druckrey, H., Preussmann, R., and Ivankovic, S., Ann. N. Y. Acad. Sci., 163, 676–696 (1969).

    Article  ADS  CAS  Google Scholar 

  9. Nomura, T., Cancer Res., 34, 2217–2231, 3363–3372 (1974).

    CAS  PubMed  Google Scholar 

  10. Nomura, T., and Okamoto, E., Gann, 63, 731–742 (1972).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

NOMURA, T. Carcinogenicity of the food additive furylfuramide in foetal and young mice. Nature 258, 610–611 (1975). https://doi.org/10.1038/258610a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/258610a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing